OpenVSafe by OpenVAERS
Search V-safe

5QZ-37295-92377

4 vaccinations 1 coded response 29 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
12-15
ZIP prefix
910 / CA
Registered
2022-01-09
Relationship
Child or adolescent in my care
Guardian
6VP-61598-78489
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-04
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-09
    Registered in v-safe
  4. 2022-01-09
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-09
    Health check-in — day 0, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  6. 2022-01-10
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  7. 2022-01-11
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  8. 2022-01-12
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-01-13
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-01-14
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-01-15
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  12. 2022-01-16
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  13. 2022-01-23
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  14. 2022-01-30
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  15. 2022-02-06
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  16. 2022-02-13
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  17. 2022-02-20
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  18. 2022-04-10
  19. 2022-07-10
  20. 2022-09-10
    Dose 4 — Pfizer-BioNTech
  21. 2022-09-10
    Health check-in — day 0, dose 4, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  22. 2022-09-11
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  23. 2022-09-12
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  24. 2022-09-13
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  25. 2022-09-14
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  26. 2022-09-16
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  27. 2022-09-17
    Health check-in — day 7, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  28. 2022-09-24
    Health check-in — day 14, dose 4, dependent
    Feeling: Good
    Adult check-in
  29. 2022-10-01
    Health check-in — day 21, dose 4, dependent
    Feeling: Good
    Adult check-in
  30. 2022-10-08
    Health check-in — day 28, dose 4, dependent
    Feeling: Good
    Adult check-in
  31. 2022-10-15
    Health check-in — day 35, dose 4, dependent
    Feeling: Good
    Adult check-in
  32. 2022-10-22
    Health check-in — day 42, dose 4, dependent
    Feeling: Good
    Adult check-in
  33. 2022-12-10
    Survey response — 3 months, dose 4, dependent
    MedDRA: Anxiety — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Severe anxiety
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-12-10
    Report sent to call center — 3 months, dose 4, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  35. 2022-12-13
  36. 2023-03-11

Vaccinations

DoseDateManufacturerCo-administered
12021-05-14Pfizer-BioNTech No
22021-06-04Pfizer-BioNTech No
32022-01-09Pfizer-BioNTech No
42022-09-10Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — 3 months, dose 4, dependent

2022-12-10

Symptoms: Severe anxiety

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…